Ronald E. Gress

National Cancer Institute — United States

Medicine · Health Sciences

78h-index30.8kcitations483works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(175), Immune Cell Function and Interaction(137), T-cell and B-cell Immunology(132), Immunotherapy and Immune Responses(125), CAR-T cell therapy research(92)

Publications483 total

Disruption of Notch signaling by KGF induces a developmental pause in thymocytes
Frontiers in Immunology·2025· 1 citedOpen Access
Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT
Blood·2025· 1 citedOpen Access
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention
Blood Advances·2024· 9 citedOpen Access
Microbial ligand-independent regulation of lymphopoiesis by NOD1
Nature Immunology·2023· 4 cited
In vivo deuterium magnetic resonance imaging of xenografted tumors following systemic administration of deuterated water
Scientific Reports·2023· 10 citedOpen Access
In vivo deuterium magnetic resonance imaging of xenografted tumors following systemic administration of deuterated water
Research Square (Research Square)·2023Open Access
Supplementary Methods and Figures 1 - 3 from B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
2023Open Access
Data from B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
2023Open Access
Data from Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer
2023Open Access
Data from Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer
2023Open Access
Supplementary Table 1 from Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer
2023Open Access
Data from B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
2023Open Access
Supplementary Methods and Figures 1 - 3 from B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
2023Open Access
Supplementary Table 1 from Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer
2023Open Access
Supplementary Figure 6 from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4<sup>+</sup> T Cells to T-Regulatory Cells
2023Open Access
Supplementary Figure 2 from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4<sup>+</sup> T Cells to T-Regulatory Cells
2023Open Access
Supplementary Figure 1 from Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
2023Open Access
Data from Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
2023Open Access
Supplementary Figure 6 from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4<sup>+</sup> T Cells to T-Regulatory Cells
2023Open Access
Supplementary Figure 8 from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4<sup>+</sup> T Cells to T-Regulatory Cells
2023Open Access
page 1 of 25Next →

Frequent Co-authors

Frances T. Hakim(17), Crystal L. Mackall(15), James N. Kochenderfer(7), Jeremy J. Rose(6), Terry J. Fry(6), Philip J. Lucas(5), Irina Marić(5), Brenna Hansen(5), Jennifer N. Brudno(4), Maryalice Stetler‐Stevenson(4), Steven A. Feldman(4), David F. Stroncek(4), Steven A. Rosenberg(4), Claude Sportès(4), Margaret R. Brown(4), Steven Z. Pavletic(3), Daniel H. Fowler(3), Sarfraz Memon(3), Thomas A. Fleisher(3), Catherine K. Chow(3)